Comment on: Exploring the utility of ctDNA testing in high-risk breast cancer patients in a community setting: case
Dana Narvaez1, Federico Waisberg2
1Department of Breast Oncology, Alexander Fleming Institute, Cramer 1180, Ciudad de Buenos Aires, Zip Code 1425, Argentina.
Therapeutic Advances in Medical Oncology
|October 14, 2025
Abstract
No abstract available in PubMed .


